Vitamin D Supplementation and Treatment-Free Survival in Early-Stage CLL: A Real-World Validation Study [0.03%]
维生素D补充与早期慢性淋巴细胞白血病无治疗生存的关系:一项真实世界验证研究
Tamar Tadmor,Ronen Arbel,Talish Razi et al.
Tamar Tadmor et al.
Background: Patients with early-stage chronic lymphocytic leukemia (CLL) are typically managed with a watch-and-wait strategy, and no intervention has been shown to modify the natural history of the disease. ...
Sézary Syndrome: Survival Trends, Racial Disparities, and Limited Prognostic Value of Routine Registry Variables [0.03%]
塞扎里综合征的生存趋势、种族差异及常规登记变量有限的预后价值
Tiantian Zhang,Weili Xue,Zhe Wang et al.
Tiantian Zhang et al.
Introduction: Sézary syndrome (SS) is a rare leukemic cutaneous T-cell lymphoma with limited contemporary population-level outcome data. Methods: ...
Salvage With Revumenib: Targeting KMT2A-Rearranged Isolated Leukemia Cutis Identified in the Extramedullary Disease [0.03%]
利用Revumenib进行挽救治疗:靶向KMT2A重排孤立性白血病皮肤受累的髓外疾病
Bana Antonios,Xuemei Wu,Lynn Johnson et al.
Bana Antonios et al.
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy associated with a high risk of relapse. Leukemia cutis is characterized by the presence of neoplastic leukocytes infiltrating the skin. Here, we present a previously treat...
Incidence and Risk Factors of Symptomatic Osteonecrosis in Children With Acute Lymphoblastic Leukemia-A Population-Based Analysis of the Austrian ALL-BFM Study Group [0.03%]
奥地利ALL-BFM研究组急性淋巴细胞白血病儿童症状性骨坏死的发病及危险因素-基于人口的研究分析
Katharina Arnold,Leila Ronceray,Martin Benesch et al.
Katharina Arnold et al.
Background: Osteonecrosis is a clinically relevant therapy-associated complication in pediatric acute lymphoblastic leukemia (ALL). Methods: ...
Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience [0.03%]
用于复发/难治慢性淋巴细胞白血病患者的Venetoclax方案比较:单中心真实世界研究经验
Benjamin Heyman,Michael Choi,Thomas J Kipps
Benjamin Heyman
Introduction: The optimal venetoclax-based treatment for patients with relapsed/refractory (R/R) CLL is still unknown, especially for high-risk patients. ...
Mosunetuzumab Successfully Treated Rituximab-Refractory Lymphoma-Associated Protein-Losing Enteropathy With Concomitant Immune Thrombocytopenia in Follicular Lymphoma: A Case Report [0.03%]
莫舒纳珠单抗治疗复发性滤泡淋巴瘤相关蛋白丢失型肠病及伴随免疫性血小板减少症的病例报告
Takashi Matsunaga,Naohi Sahara,Mai Mizusawa et al.
Takashi Matsunaga et al.
Protein-losing enteropathy (PLE) is a rare but potentially severe complication of malignant lymphoma characterized by excessive gastrointestinal loss of plasma proteins, leading to hypoalbuminemia, edema, and serous effusions. We report a c...
Clinical Profile and Chemotherapy Outcomes of Adult Lymphoma Patients at Jimma University Medical Center: A 2-Year Retrospective Study [0.03%]
吉玛大学医学中心成人淋巴瘤患者临床特征及化疗结局回顾性研究
Kisi Chemeda Gutema,Ramadan Jemal Dekema,Rahmeto Kedir Gudiso et al.
Kisi Chemeda Gutema et al.
Background: Lymphoma, including Hodgkin (HL) and non-Hodgkin (NHL) subtypes, is a leading non-infectious cause of morbidity and mortality in Ethiopia. Diagnosis relies on histopathology with immunohistochemistry or flow c...
Diagnosing and Managing Paradoxical Deep Vein Thrombosis in a Patient With Congenital Afibrinogenemia [0.03%]
先天性低纤维蛋白原血症患者继发矛盾深静脉血栓的诊断与治疗
Altamash Jawadi,Malik Alqawasmi,Mahmoud Abdelsamia et al.
Altamash Jawadi et al.
Congenital afibrinogenemia, classically a bleeding disorder, can paradoxically predispose to thrombosis, potentially due to disruptions in fibrin-mediated thrombin clearance and plasmin activation. A young man with reported congenital afibr...
Cold Agglutinin Disease-Like Genetic Signatures in Lymphoplasmacytic Lymphoma-Like Cases Challenge the WHO Fifth Edition Classification [0.03%]
冷凝集素病样的遗传特征对淋巴浆细胞样肿瘤的世卫组织第五版分类提出挑战
Yuki Sato,Daisuke Koyama,Shoki Yamada et al.
Yuki Sato et al.
Background: The fifth edition of the World Health Organization (WHO) classification defines cold agglutinin disease (CAD) as a clonal B-cell lymphoproliferative disorder occurring in the absence of overt lymphoma, whereas...
BCMA CAR T for AL Amyloidosis After Plasmacytic Relapse of Lymphoplasmacytic Lymphoma [0.03%]
淋巴浆细胞淋巴瘤浆细胞复发后淀粉样变病治疗的BCMA CAR-T疗法
Nadia Al Haddad,Eugene Brailovski,Jacqueline Dela-Pena et al.
Nadia Al Haddad et al.
Introduction: Lambda immunoglobulin light chain (AL) amyloidosis associated with non-IgM lymphoplasmacytic lymphoma (LPL) is rare and often refractory to conventional therapies. Treatment options for relapsed disease rema...